An absolute risk reduction of 2.3%
Conclusions Although there is plenty of data on the anabolic potential of GH, IGF-I, and insulin and on their safety and efficacy at physiologic doses, most of this information comes from their therapeutic use in other settings (AGHD, diabetes), or from pathological disorders characterized by hormone hypersecretion (acromegaly, insulinoma)
Laws and regulations can vary in other countries, where certain peptides may be classified or controlled differently
However, it's generally advisable to wait until you've been on a stable dose of Wegovy for at least 2-3 months before pursuing formal intolerance testing, as medication-related symptoms often improve with time
Poor storage does not just reduce effectiveness
This results in improved blood sugar control